Narrative review comparing pharmacological synergies and divergences between Parkinson's disease and type 2 diabetes mellitus, emphasizing shared metabolic and inflammatory pathways and their therapeutic implications.

By linking metabolic/inflammatory mechanisms (and potential repurposing of diabetes drugs) to neurodegeneration, the paper could guide translational strategies for PD, but its narrative format and missing abstract reduce immediate actionability.